Akademisyen
MEHMET DEMİR
PROFESÖR
HATAY MUSTAFA KEMAL ÜNİVERSİTESİ TAYFUR ATA SÖKMEN TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Gastroenteroloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 44
- Proje 0
- Kitap 31
- Bildiri 26
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
12
Q2
13
Q3
15
Q4
2
WoS (JCR)
Q1
4
Q2
7
Q3
20
Q4
12
TR Index
6
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
6
Ort. yüzdelik
71.5%
Üst %1 payı
0.0%
Üst %10 payı
16.7%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 84.8%
- 2023 The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 55.8%
- 2022 Characteristics of patients with hepatocellular carcinoma: A multicenter study YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 69.2%
- 2020 The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists YÖKSİS SJR Q3 JCR Q4
- 2020 Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region YÖKSİS SJR Q3 JCR Q4
- 2020 Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Om-bitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience YÖKSİS SJR Q1 JCR Q1 OpenAlex 58.8%
- 2020 NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey YÖKSİS SJR Q1 JCR Q2
- 2020 Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection YÖKSİS SJR Q4 JCR Q4 OpenAlex 57.3%
- 2020 Genotype Distribution of Hepatitis C Virus in Hatay Province of Turkey YÖKSİS SJR Q4 JCR Q4
- 2019 Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort YÖKSİS SJR Q1 JCR Q2 OpenAlex 83.2%
- 2019 Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics YÖKSİS OpenAlex 87.2%
- 2018 Macroscopic Portal Vein Thrombosis in HCC Patients YÖKSİS SJR Q2 JCR Q4 OpenAlex 83.8%
- 2018 Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients YÖKSİS SJR Q1 JCR Q3 OpenAlex 77.2%
- 2018 C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. YÖKSİS SJR Q1 JCR Q2 OpenAlex 84.6%
- 2018 HCC with low- and normal-serum alpha-fetoprotein levels YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.9%
- 2016 Fragmented QRS is associated with cirrhotic cardiomyopathy in patients withdecompensated cirrhosis YÖKSİS SJR Q3 JCR Q4
- 2016 Nail changes in patients with inflammatory bowel diseases YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 2.1%
- 2016 High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis YÖKSİS SJR Q2 JCR Q4
- 2016 Nasobiliary Drainage for Benign Recurrent Intrahepatic Cholestasis in Patients Refractory to Standard Therapy YÖKSİS SJR Q2 JCR Q4
- 2015 Differences in nephrotoxicity risk and renal effects among anti viral therapies against hepatitis B YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.5%